Glenmede Disciplined International EqPtf holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Glenmede Disciplined International Equity Portfolio GTCIX
- NAV / 1-Day Return 22.35 / −0.58 %
- Total Assets 105.4M
-
Adj. Expense Ratio
0.850%
- Expense Ratio 0.960%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 1.01%
- Turnover 76%
USD | NAV as of Jun 09, 2026 | 1-Day Return as of Jun 09, 2026, 12:11 AM GMT+0
Morningstar’s Analysis GTCIX
Will GTCIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the GTCIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of GTCIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Shell PLC | 1.66 | 2M | Energy |
Astellas Pharma Inc | 1.59 | 1M | Healthcare |
Eni SpA | 1.57 | 1M | Energy |
Ipsen SA | 1.57 | 1M | Healthcare |
Lasertec Corp | 1.55 | 1M | Technology |
Sanofi SA | 1.54 | 1M | Healthcare |
Enel SpA | 1.52 | 1M | Utilities |
Suncor Energy Inc | 1.52 | 1M | Energy |
Yara International ASA | 1.48 | 1M | Basic Materials |
GSK PLC | 1.47 | 1M | Healthcare |
United States